The Precision Peptide Company Inc.
BPC
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.84% | -449.35% | -100.81% | -59.10% | 60.43% |
| Total Depreciation and Amortization | -- | 1.83% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.44% | 5,401.61% | -189.88% | -- | -- |
| Change in Net Operating Assets | 109.49% | -183.31% | 129.65% | 2,230.77% | -95.64% |
| Cash from Operations | 61.45% | -4,063.06% | -362.07% | 95.60% | 4.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 159.23% | -158.77% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -81.93% | 189.92% | -70.45% | -- | -- |
| Total Debt Issued | -- | -- | -- | -200.00% | -80.90% |
| Total Debt Repaid | -- | 78.58% | -391.72% | -- | -- |
| Issuance of Common Stock | -- | -- | 814.29% | -3.92% | -15.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.40% | -87.69% | 892.98% | -13.04% | -21.91% |
| Foreign Exchange rate Adjustments | -447.37% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.17% | -150.88% | 2,713.70% | -193.21% | -54.50% |